Singleton Mark Leonard 4

What Happened

• Mark Leonard Singleton, SVP & CFO of Bioventus Inc., received 20,153 shares upon conversion/exercise of vested restricted stock units (RSUs) on February 15, 2026. The filing shows 9,429 of those shares were surrendered to cover tax withholding at $8.27/share (total withheld ≈ $77,978), resulting in a net receipt of 10,724 shares. The gross value of the vested shares at $8.27/share was about $166,665.
• This was not an open-market purchase or a sale for investment purposes but the routine settlement of compensation awards (RSU vesting), with shares withheld to satisfy tax liabilities.

Key Details

• Transaction date: 2026-02-15; Form 4 filed 2026-02-18.
• Transactions reported: conversion/exercise of derivative (RSU settlement) — 20,153 shares acquired; tax withholding — 9,429 shares disposed at $8.27/share for $77,978; net shares retained ≈ 10,724.
• Codes: M = exercise/conversion of derivative (RSU settlement); F = payment of tax liability via share withholding.
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnotes: F1 — each RSU equals a contingent right to one share; F2 — RSUs vest in four roughly equal annual installments starting Feb 15, 2024 (this appears to be one installment vesting).

Context

• This is a routine compensation event (RSU vesting) rather than a market buy or sell. The withholding of shares to cover taxes is common and effectively a cashless settlement of the tax obligation.
• For retail investors: award settlements like this reflect compensation mechanics and do not by themselves signal the insider buying or selling for investment reasons.